Carlo Cavallero, graduated in Chemical Engineering at Politecnico of Turin (Italy) and holds a Master of Business Administration –MBA from SDA Bocconi (Italy). Carlo began his professional career in Montefluos (Montedison group) as a process engineer with numerous experiences in Italy and Japan (Asahi Glass JV) specifically in the predelivery and start up of new plants. Next, he developed unique skills in Marketing and Operational and Strategic Planning working for companies as Gilardini/Magneti Marelli CNH and New Holland Industrial. From 2004 to 2007 he held the position of Chairman of the World Trade Commission of the CECE (European trade association) while in 2009 he began a collaboration with the University of Turin both as Lecturer in Research, Technology, Innovation at the Doctoral School. Since 2012, Carlo is co-founder and CEO of Corion Biotech S.r.l.

Tullia Todros, MD and Full Professor in Obstetrics & Gynaecology at the University of Turin (Italy), was the  Director of Gynaecology & Obstetrics 2U Unit at “Città della Salute e della Scienza – S.Anna Hospital” in Turin (Italy), the biggest center for fetal-maternal and neonatal medicine in Europe. She has 30+ years of clinical and scientific experience in Fetal-Maternal Medicine, Preeclampsia and Pregnancy-related disorders. She is author and co-author of more than 200 clinical-scientific publications in international indexed high impact peer-review journals. In 2012, Tullia co-founded Corion Biotech S.r.l. She is Chief Medical Officer and former President of the Company.

Alessandro Rolfo, Doctor in Medical Biotechnology with a PhD in Clinical Sciences and Human Reproduction at the University of Turin (Italy), is Associate Professor in Obstetrics & Gynaecology at the Dept. Of Surgical Sciences of the University of Turin (Italy). Alessandro has 20+ years of experience in pregnancy physiopathology, physiopathological human placentation, fetal-maternal medicine and placenta-derived mesenchymal stem cells applications for women’s health. Since 2012, Alessandro is co-founder and Chief Scientific Officer of Corion Biotech S.r.l.

Luisa Bertarione is graduated in Biotechnology and has a Ph.D. in Biochemistry from the University of Turin (Italy). She has more than 15 years of experience in pharmaceutical product development, from discovery to Phase II clinical trials. Prior to joining Corion Biotech S.r.l, she worked as Principal Scientist II in Advanced Accelerator Applications, a Novartis Company focused on nuclear medicine for cancer treatment. Previously she was appointed as Associate Director, Research in Sienna Biopharmaceuticals, a biopharmaceutical company focused on immunology and inflammation.

Katia Rolfo is graduated in Biological Science at Univ. of Turin (Italy) with a PhD in Toxicology Application at Guildford Univ. (UK), a master’s in clinical chemistry in Siena Univ. (Italy) and a master’s in clinical nutrition at Rome Univ. (Italy). She worked in Advanced Accelerator Applications, a Novartis company, as Preclinical Quality and Submission Manager, and in Merck Italia, as Toxicology Manager in Preclinical Science. With + 20 years of experience in the pharmaceutical industry she has in-depth knowledge of regulatory and quality aspects of preclinical drug development in different therapeutic areas.

Marlisa Gatto, Doctor in Medical Biotechnologies, is attending the three-years industrial PhD program in “Medicine and Experimental Therapy” at the University of Turin (Italy) held in collaboration among Corion Biotech S.r.l and the Departments of Clinical & Biological Sciences and Surgical Sciences of the University of Turin.